Arrowhead Pharmaceuticals, Inc.

AQR CAPITAL MANAGEMENT LLC ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

147,353

Value ($000)

9,783

Weight

0.0%

2019 Q4 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	9,783	0.0%	147,353	12/31/2025
2025 Q3	11/14/2025	4,926	0.0%	142,825	9/30/2025
2025 Q2	8/14/2025	2,407	0.0%	152,351	6/30/2025
2025 Q1	5/15/2025	514	0.0%	40,506	3/31/2025
2022 Q4	2/14/2023	241	0.0%	6,024	12/31/2022
2022 Q3	11/14/2022	759	0.0%	22,952	9/30/2022
2022 Q2	8/15/2022	652	0.0%	19,540	6/30/2022
2022 Q1	5/16/2022	5,362	0.0%	116,598	3/31/2022
2021 Q4	2/14/2022	3,204	0.0%	48,330	12/31/2021
2021 Q3	11/15/2021	3,565	0.0%	57,593	9/30/2021
2021 Q2	8/16/2021	3,705	0.0%	45,166	6/30/2021
2021 Q1	5/17/2021	1,721	0.0%	25,954	3/31/2021
2020 Q4	2/16/2021	2,749	0.0%	36,098	12/31/2020
2020 Q3	11/16/2020	3,076	0.0%	71,426	9/30/2020
2020 Q2	8/17/2020	12,103	0.0%	286,330	6/30/2020
2020 Q1	5/15/2020	12,602	0.0%	438,025	3/31/2020
2019 Q4	2/14/2020	8,005	0.0%	126,196	12/31/2019